Local Storage seems to be disabled in your browser.
For the best experience on our site, be sure to turn on Local Storage in your browser.
Improvac 100 ml
One dose (2 ml) contains: Gonadotropin releasing factor (GnRF) analogue-protein conjugate (a synthetic peptide analogue of GnRF conjugated to diphtheria toxoid) min. 300 mcg
Induction of antibodies against GnRF to produce a temporary immunological suppression of testicular function. For use as an alternative to physical castration for the reduction of boar taint caused by the key boar taint compound androstenone, in entire male pigs following the onset of puberty. Another key contributor to boar taint, skatole, may also be reduced as an indirect effect. Aggressive and sexual (mounting) behaviours are also reduced.
The onset of immunity (induction of anti-GnRF antibodies) can be expected within 1 week post second vaccination. Reduction of androstenone and skatole levels has been demonstrated from 4 to 6 weeks post second vaccination. This reflects the time needed for clearance of boar taint compounds already present at the time of vaccination as well as the variability of response between individual animals. Reduction of aggressive and sexual (mounting) behaviours can expected from 1 to 2 weeks
Dosage and administration
Improvac is for subcutaneous use. Entire male pigs from 8 weeks of age onwards should be vaccinated with 2 doses of 2 ml at least 4 weeks apart, with the second dose normally given 4 to 6 weeks prior to slaughter.
|Registration number||REG NL 101060|
|Active Ingredient||Gonadotrophin Releasing Factor (GnRF) analog-protein conjuga|
|Target species||Male Pig (from 8 weeks)|
|Legal status of supply||UDD|
|Withdrawal period||0 days|
|Expiry date||Sep 30, 2023|
|Units per outer box||1|
|Ingredients||One dose (2 ml) contains: Gonadotropin releasing factor (GnRF) analogue-protein conjugate (a synthetic peptide analogue of GnRF conjugated to diphtheria toxoid) min. 300 mcg|